Evidence map›Paper›PMID 36103464›Full record

ArticlePloS one2022

Presepsin cut-off value for diagnosis of sepsis in patients with renal dysfunction.

Kimika Arakawa, Ayako Saeki, Reo Ide, Yoshiteru Matsushita

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kimika ArakawaDepartment of Clinical Laboratory, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.ORCID 0000-0002-4368-089X
Ayako SaekiDepartment of Clinical Laboratory, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
Reo IdeDepartment of Clinical Laboratory, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
Yoshiteru MatsushitaDepartment of Clinical Laboratory, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
National Kyushu Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Presepsin is used as a marker for diagnosing sepsis, but its serum concentration is affected by renal function. We investigated the effect of the estimated glomerular filtration rate (eGFR) determined by creatinine on the diagnostic accuracy of presepsin to identify the optimal cut-off value in patients with renal dysfunction. A total of 834 patients aged ≥18 years with serum presepsin and creatinine measured on the same day over a period of 1 year were included. Sepsis was diagnosed in three ways: sepsis-1, sepsis-3, and clinical diagnosis (Sep-C). Presepsin showed a significant negative correlation with eGFR (r = -0.55, p<0.01), with median and interquartile ranges of presepsin values for patients in each eGFR category as follows: ≥90, 263 (169-460); ≥60-<90, 309 (205-578); ≥45-<60, 406 (279-683); ≥30-<45, 605 (379-1109); ≥15-<30, 1027 (675-1953); <15, 1977 (1199-3477); and on hemodialysis, 3964 (2343-6967). In receiver operating characteristic (ROC) analysis, the area under the curve (AUC) for sepsis-1 was the lowest (0.64 ± 0.02), while Sep-C (0.80± 0.03) and sepsis-3 (0.75 ± 0.03) were moderately accurate. Comparing AUCs after dividing patients into eGFR ≥60 and <60 showed that the AUC of Sep-C was lower in the eGFR ≥60 group, while the AUC of sepsis-3 was ≥ 0.7 in both groups. The following cut-offs were obtained by ROC analysis for sepsis-3: 466 pg/mL in the ≥60 group and 960 pg/mLin the < 60 group. Presepsin facilitated diagnosis sepsis based on sepsis-3 criteria regardless of renal function. We found that the optimal cut-offs for patients in this study were 500 pg/mL for eGFR ≥ 60 and 1000 pg/mL for < 60. However, future prospective diagnostic studies on sepsis-3 are needed to determine the cut-offs for patients with renal dysfunction.

Indexed as

Kidney DiseasesSepsisAdolescentAdultCreatinineHumansLipopolysaccharide ReceptorsPeptide FragmentsCreatinineLipopolysaccharide ReceptorsPeptide Fragmentspresepsin protein, human

Identifiers

PMID36103464
PMCPMC9473387
OpenAlexW4295756089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.